Study to evaluate the safety and tolerability of Streptococcus salivarius eK12, a genetically modified strain derived from the oral probiotic S. salivarius K12: Results from a randomized, double-blind, placebo-controlled, parallel-group clinical trial.

Di Pierro F, Bugti AA, Bano A, Kara M, Ujjan I, Mumtaz N, Gull Y, Cazzaniga M, Bertuccioli A, Tanda ML, Zerbinati N, Hameed S, Khan A.

Open source

DOI: 10.3389/fnut.2025.1701611
Published: 2025-12-08
Container: Front Nutr
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fnut.2025.1701611,
  title = {Study to evaluate the safety and tolerability of \&lt;i\&gt;Streptococcus salivarius\&lt;/i\&gt; eK12, a genetically modified strain derived from the oral probiotic S. \&lt;i\&gt;salivarius\&lt;/i\&gt; K12: Results from a randomized, double-blind, placebo-controlled, parallel-group clinical trial.},
  author = {Di Pierro F and  Bugti AA and  Bano A and  Kara M and  Ujjan I and  Mumtaz N and  Gull Y and  Cazzaniga M and  Bertuccioli A and  Tanda ML and  Zerbinati N and  Hameed S and  Khan A.},
  year = {2025},
  journal = {Front Nutr},
  doi = {10.3389/fnut.2025.1701611},
  url = {https://doi.org/10.3389/fnut.2025.1701611}
}

RIS

TY  - JOUR
TI  - Study to evaluate the safety and tolerability of &lt;i&gt;Streptococcus salivarius&lt;/i&gt; eK12, a genetically modified strain derived from the oral probiotic S. &lt;i&gt;salivarius&lt;/i&gt; K12: Results from a randomized, double-blind, placebo-controlled, parallel-group clinical trial.
AU  - Di Pierro F
AU  -  Bugti AA
AU  -  Bano A
AU  -  Kara M
AU  -  Ujjan I
AU  -  Mumtaz N
AU  -  Gull Y
AU  -  Cazzaniga M
AU  -  Bertuccioli A
AU  -  Tanda ML
AU  -  Zerbinati N
AU  -  Hameed S
AU  -  Khan A.
PY  - 2025
JO  - Front Nutr
DO  - 10.3389/fnut.2025.1701611
UR  - https://doi.org/10.3389/fnut.2025.1701611
ER  -

APA

F, D. P., AA, B., A, B., M, K., I, U., N, M., Y, G., M, C., A, B., ML, T., N, Z., S, H., & A., K. (2025). Study to evaluate the safety and tolerability of Streptococcus salivarius eK12, a genetically modified strain derived from the oral probiotic S. salivarius K12: Results from a randomized, double-blind, placebo-controlled, parallel-group clinical trial.. Front Nutr. https://doi.org/10.3389/fnut.2025.1701611

Source records

europe-pmc · retrieved 2026-09-26T02:35:07.716Z
doaj · retrieved 2026-09-26T02:35:07.736Z

Study to evaluate the safety and tolerability of &lt;i&gt;Streptococcus salivarius&lt;/i&gt; eK12, a genetically modified strain derived from the oral probiotic S. &lt;i&gt;salivarius&lt;/i&gt; K12: Results from a randomized, double-blind, placebo-controlled, parallel-group clinical trial.

Credibility signals

Cite this work

BibTeX

RIS

APA

Source records

Study to evaluate the safety and tolerability of <i>Streptococcus salivarius</i> eK12, a genetically modified strain derived from the oral probiotic S. <i>salivarius</i> K12: Results from a randomized, double-blind, placebo-controlled, parallel-group clinical trial.